Drug and target discovery with explainable AI.
Learn how explainable AI is enabling researchers to gain a deeper understanding of complex biological systems, uncover hidden patterns, and make more informed decisions.
SAE Media Group’s 14th Annual Conference – RNA Therapeutics.
Investigating the next generation of genetic medicine through RNA-based therapies.
Oligonucleotide Therapeutics Society
OTS is a forum to foster academic and industry-based research and development of oligonucleotide therapeutics.
Nordic Digital Science & Innovation Day
Sharing the latest trends, innovations, and best practices for digitizing R&D assets to accelerate modern science.
Abzu increased safe lead candidates by 20% for top-10 pharmaceutical company.
Abzu increased safe lead candidates by 20% for an undisclosed top-10 pharmaceutical company.
siRNA molecule activity: explainable AI models uncover underlying mechanisms
Our results-driven world pressures us to give up good science.
Abzu® and Contera Pharma partner to design RNA therapeutics for rare diseases with explainable AI.
The two companies aim to have a rapid target screening application available this year, enabling Contera Pharma to advance better nucleic acid-based therapeutics towards clinic development.
AI and nucleic acid-based medicine: can symbolic regression unite them?
How the QLattice explains the cellular toxicity of RNA-targeting drugs.
